Status:
UNKNOWN
Pozzi Forceps in Intrauterine Insemination
Lead Sponsor:
CHU de Quebec-Universite Laval
Conditions:
Infertility
Insemination
Eligibility:
FEMALE
18-40 years
Phase:
NA
Brief Summary
Many infertility and subfertility issues are treated nowadays with intrauterine inseminations. This is a minimally invasive technique that consists in placing sperm into a woman's uterus. Insemination...
Detailed Description
Once the initial investigations are done, an oral treatment is started on the first cycle if medically indicated. At mid-cycle, patients undergo a transvaginal ultrasound looking for follicles' matur...
Eligibility Criteria
Inclusion
- Infertility :Defined as no pregnancy after one year of regular unprotected vaginal intercourse
- Infertility secondary to endometriosis, to a mild to moderate male factor, to an ovulatory dysfunction, an unexplained infertility or any other known medical indication for IUI.
- Intrauterine insemination with a partner's semen sample or a donor sample
- First IUI treatment or first treatment since last pregnancy
- Ovulation induction with letrozole medication
- Being able to speak and understand French
Exclusion
- Bilateral tubal occlusion
- Active pelvic infection
- \< 1 X 10\^6 mobile sperm on semen analysis
Key Trial Info
Start Date :
June 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2023
Estimated Enrollment :
800 Patients enrolled
Trial Details
Trial ID
NCT03435809
Start Date
June 1 2019
End Date
January 1 2023
Last Update
February 5 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHUL Centre Mère Enfant Soleil - CHU de Quebec
Québec, Quebec, Canada, G1V 4G2